Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001250853-18-000041)

Filing Details

Accession Number:: 0001250853-18-000041
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-14 20:32:30
Reporting Period:: 2018-03-12

Accepted Time:: 2018-03-14 20:32:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561743	Kindred Biosciences Inc.	KIN	Pharmaceutical Preparations (2834)	461160142

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1593867	Raymond Townsend	C/O Kindred Biosciences, Inc. 1555 Bayshore Highway, Suite 200 Burlingame CA 94010		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-03-12	91	$3.45	23,233	No	4	M	Direct
Common Stock	Disposition	2018-03-12	91	$9.45	23,142	No	4	S	Direct
Common Stock	Acquisiton	2018-03-12	155	$3.45	23,297	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2018-03-12	91	$0.00	91	$3.45
Common Stock	Stock Option (right to buy)	Disposition	2018-03-12	155	$0.00	155	$3.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
26,348		2026-01-08	No	4	M	Direct
26,193		2026-01-08	No	4	M	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2017.
The option vested 25% quarterly following January 8, 2016, the date of grant.